Skip to main content
Signal8

XBiotech Inc. (XBIT)

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

XBiotech Inc. logo

XBiotech Inc.

NASDAQ:XBITHealthcare
-3.09%$1.88
AH$1.88+0.00%vs close
Mkt Cap$57.32M
Float22.25M
O/S30.49M
Vol
$ Vol
RVOL
Inst Own6.5%
SI1.4%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$45.54M
Total Assets$150.08M
Free Cash Flow-$40.21M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$140.35M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in XBIT's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$150.08M
Liabilities$9.73M
Accounts Receivable$360K
Accounts Payable$1.53M
Inventory$0
PP&E (Net)$23.13M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$0$0$0$4.01M$18.39M$44M$0$0$0$0$0$0$0$0
YoY Growth----78.2%-58.2%---------
Cost of Revenue$1.69M$0$0$651K$5.82M$34.55M$2.36M$2.43M$1.48M$698K$699K$664K$784K$946K
Gross Profit-$1.69M$0$0$3.36M$12.57M$9.45M-$2.36M-$2.43M-$1.48M-$698K-$699K-$664K-$784K-$946K
Gross Margin---83.8%68.4%21.5%--------
Research and Development$47.39M$37.76M$32.85M$31.54M$28.27M$9.53M$24.09M$15.72M$26.42M$42.49M$31.31M$14.33M$7.93M$13.33M
Selling, General, and Administrative$8.29M$4.71M$4.66M$6.3M$9.39M$18.2M$4.78M$5.27M$7.63M$10.28M$6.2M$7.45M$1.99M$1.83M
Other-$1.69M$0$0$0$0$0$0-$2.43M-$1.48M-$698K-$699K-$664K-$784K-$946K
Total Operating Expenses$54M$42.47M$37.51M$37.85M$37.66M$27.73M$28.87M$18.56M$32.58M$52.06M$36.81M$21.11M$9.14M$14.22M
Operating Income (EBIT)-$55.69M-$42.47M-$37.51M-$34.49M-$25.08M-$18.28M-$31.23M-$20.99M-$34.06M-$52.76M-$37.51M-$21.78M-$9.93M-$15.16M
Operating Margin----860.1%-136.4%-41.5%--------
Interest Expense$88K$807K$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$5.68M$9.81M$10.42M$3.82M$467K$2.46M$564K$400K$354K$49K$0$1K$1K$3K
Other Income (Expense)$10.38M$3.91M$13.2M$902K-$376K$5.45M$749.69M-$144K$909K$2K$27K$54K-$2K$3K
Income Before Tax (EBT)-$45.3M-$38.56M-$24.31M-$33.59M-$25.46M-$12.83M$718.45M-$21.14M-$33.15M-$52.76M-$37.48M-$21.72M-$9.93M-$15.16M
Income Tax Expense$235K-$32K$244K-$688K-$8.04M-$1.61M$49.82M$0$0-$2K-$6K-$54K$0$0
Net Income-$45.54M-$38.53M-$24.56M-$32.9M-$17.41M-$11.22M$668.63M-$21.14M-$33.15M-$52.76M-$37.48M-$21.72M-$9.93M-$15.16M
Net Income Margin----820.4%-94.7%-25.5%--------
Supplementary Data
EPS-1.49-1.26-0.81-1.08-0.58-0.3617.17-0.59-0.95-1.63-1.22-0.68-0.31-0.48
Diluted EPS-1.49-1.26-0.81-1.08-0.58-0.3614.44-0.59-0.95-1.63-1.22-0.68-0.31-0.48
Weighted Average OS30.49M30.46M30.32M30.44M30.04M30.82M38.95M35.80M34.88M32.40M30.80M31.72M31.72M31.72M
EBITDA-$43.53M-$36.01M-$22.57M-$30.97M-$22.81M-$16.04M$720.81M-$18.7M-$32.58M-$52.06M-$36.81M-$21.11M-$9.14M-$14.21M
EBITDA Margin----772.4%-124.0%-36.5%--------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$125.55M$172.68M$200.02M$157.31M$236.98M$237.37M$714.59M$15.82M$31.77M$34.32M$91.05M$57.33M$7.24M$4.17M
Short-Term Investments$0$0$0$60.17M$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$125.55M$172.68M$200.02M$217.48M$236.98M$237.37M$714.59M$15.82M$31.77M$34.32M$91.05M$57.33M$7.24M$4.17M
Accounts Receivable$360K$858K$935K$1.76M$8.95M$4.11M$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$1.04M$1.03M$760K$601K$0$83.81M$1.67M$0$0$0$0$324K$0$0
Total Current Assets$126.95M$174.57M$201.72M$219.84M$246.87M$325.88M$716.26M$17.02M$33.33M$36.93M$93.04M$58.06M$7.69M$4.36M
Long-Term Assets
Property, Plant & Equipment Net$23.13M$24.53M$24.9M$26.26M$28.31M$27.34M$25.17M$27.33M$29.64M$30.12M$16.32M$4.11M$3.38M$4.11M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$75M$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$1.66M$1.09M$533K$443K$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0-$1.66M-$1.09M$0$75M$0$0$0$0$0$0$0
Total Long-Term Assets$23.13M$24.53M$24.9M$26.26M$28.31M$27.87M$100.61M$27.33M$29.64M$30.12M$16.32M$4.11M$3.38M$4.11M
Other Assets$0$0$0$0-$1K$0$0$0$0$0$0$0$0$0
Total Assets$150.08M$199.09M$226.62M$246.1M$275.18M$353.74M$816.88M$44.34M$62.97M$67.05M$109.36M$62.18M$11.07M$8.47M
Liabilities
Current Liabilities
Accounts Payable$1.53M$2.22M$2.52M$2.41M$2.07M$2.49M$2.15M$1.65M$1.73M$4.43M$4.83M$1.63M$561K$457K
Short-Term Debt$0$10.25M$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$76K$1.72M$83K$55K$10K$142K$49.36M$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$4.5M$0$0$0$0$0$0$0
Other Current Liabilities$5.18M$611K$562K$1.17M$904K$1.05M$53.2M$0$0$521K$421K$0$0$161K
Total Current Liabilities$7.93M$15.11M$6.1M$4.07M$3.45M$3.98M$60.19M$2.94M$2.79M$7.96M$6.29M$3.15M$845K$1.07M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$5K$0$0$59K$873K$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$1.8M$1.72M$1.67M$1.58M$1.47M$1.12M$1.06M$3K$18K$23K$17K$0$0$29K
Total Long-Term Liabilities$1.8M$1.72M$1.67M$1.64M$2.34M$1.12M$1.06M$3K$18K$23K$17K$0$0$30K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$9.73M$16.82M$7.77M$5.7M$5.79M$5.11M$61.25M$2.95M$2.81M$7.99M$6.31M$3.15M$845K$1.1M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$276.73M$273.11M$271.15M$267.32M$262.26M$249.81M$324.81M$279.35M$277.49M$242.42M$233.9M$152.35M$81.81M$69.02M
Retained Earnings-$136.38M-$90.84M-$52.31M-$27.75M$5.15M$97.57M$430.93M-$237.7M-$216.56M-$183.41M-$130.65M-$93.17M-$71.44M-$61.52M
Comprehensive Income & Other$0$0$0$826K$1.97M$1.27M-$106K-$255K-$768K$57K-$201K-$153K-$135K-$134K
Other Stockholders' Equity$0$0$0$826K$1.97M$1.27M-$106K-$255K-$768K$57K-$201K-$153K-$135K-$134K
Total Equity$140.35M$182.27M$218.85M$240.4M$269.38M$348.64M$755.63M$41.4M$60.16M$59.06M$103.05M$59.03M$10.23M$7.37M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$150.08M$199.09M$226.62M$246.1M$275.18M$353.74M$816.88M$44.34M$62.97M$67.05M$109.36M$62.18M$11.07M$8.47M
Supplementary Data
Total Debt$0$10.25M$0$0$0$0$0$0$0$0$0$0$0$1K
Net Debt-$125.55M-$162.43M-$200.02M-$157.31M-$236.98M-$237.37M-$714.59M-$15.82M-$31.77M-$34.32M-$91.05M-$57.33M-$7.24M-$4.17M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$45.54M-$38.53M-$24.56M-$32.9M-$17.41M-$11.22M$668.63M-$21.14M-$33.15M-$52.76M-$37.48M-$21.72M-$9.93M-$15.16M
Depreciation & Amortization$1.69M$1.75M$1.74M$2.61M$2.65M$2.24M$2.36M$2.43M$1.48M$698K$699K$664K$784K$946K
Deferred Income Tax$5K$0$0$0$0-$90K-$444K$0$0$0$0$0$0$0
Stock-Based Compensation$3.62M$1.75M$3.26M$5.06M$4.46M$12.58M$3.36M$1.66M$1.75M$5.57M$4.41M$7.02M$739K$2.82M
Changes in Working Capital:
  Accounts Receivable$574K$77K$829K$7.34M$1.73M-$10.69M$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable-$688K-$364K$91K$357K-$514K-$334K$496K-$78K-$2.7M-$981K$840K$1.07M$103K-$199K
  Other Working Capital$3.75M-$1.17M$1.8M-$97K$78.53M-$57.73M-$18.11M$586K-$1.43M$1.46M-$1.61M$1.27M-$607K-$37K
Total Working Capital Change$3.64M-$1.46M$2.72M$7.6M$79.75M-$68.75M-$17.62M$508K-$4.13M$475K-$774K$2.34M-$504K-$236K
Other Non-Cash Items-$3.33M$5.53M-$1.89M$2.8M$0$90K-$674.56M$0$401K$0-$157K$0$0$0
Net Cash from Operating-$39.92M-$30.96M-$18.73M-$14.82M$69.44M-$65.15M-$18.27M-$16.54M-$33.65M-$46.02M-$33.31M-$11.7M-$8.91M-$11.63M
Investing Activities
Capital Expenditures-$289K-$1.3M-$362K-$585K-$3.52M-$3.73M-$204K-$122K-$1.41M-$13.91M-$10.39M-$1.4M-$59K-$550K
Acquisitions$0$0$0$0$0$0$675M$0$0$0$0$0$0$0
Purchases of Investments$0$0$0-$63.31M$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$61.86M$0$0$0$0$0$0$0$0$0$0$0
Net Cash from Investing-$289K-$1.3M$61.5M-$63.89M-$3.52M-$3.73M$674.8M-$122K-$1.41M-$13.91M-$10.39M-$1.4M-$59K-$550K
Financing Activities
Debt Repaid--------------
Common Stock Issuance$0$0$5K$0$8M$0$38.06M$201K$32.62M$1.81M$75.71M$63.52M$12.04M$7.28M
Common Stock Repurchases$0$0$0$0$0-$420M$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0-$75M$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$200K-$14K$0$0$10.28M$4.03M$0$703K$1.14M$1.76M-$174K$0$135K
Net Cash from Financing-$10.25M$10.45M-$9K$0-$67.01M-$409.72M$42.1M$201K$33.32M$2.94M$77.47M$63.2M$12.04M$7.28M
Forex Effect$3.33M-$5.53M-$46K-$961K$705K$1.37M$149K$513K-$825K$258K-$48K-$18K-$1K$0
Net Change in Cash-$47.13M-$27.35M$42.72M-$79.68M-$383K-$477.23M$698.77M-$15.95M-$2.56M-$56.73M$33.72M$50.09M$3.08M-$4.9M
Supplementary Data
Operating Cash Flow-$39.92M-$30.96M-$18.73M-$14.82M$69.44M-$65.15M-$18.27M-$16.54M-$33.65M-$46.02M-$33.31M-$11.7M-$8.91M-$11.63M
Capital Expenditure-$289K-$1.3M-$362K-$585K-$3.52M-$3.73M-$204K-$122K-$1.41M-$13.91M-$10.39M-$1.4M-$59K-$550K
Free Cash Flow-$40.21M-$32.27M-$19.09M-$15.41M$65.92M-$68.88M-$18.47M-$16.66M-$35.05M-$59.93M-$43.7M-$13.1M-$8.97M-$12.18M
Cash at Beginning$172.68M$200.02M$157.31M$236.98M$237.37M$714.59M$15.82M$31.77M$34.32M$91.05M$57.33M$7.24M$4.17M$9.07M
Cash at End$125.55M$172.68M$200.02M$157.31M$236.98M$237.37M$714.59M$15.82M$31.77M$34.32M$91.05M$57.33M$7.24M$4.17M